Are statins of clinical benefit in patients with established systolic chronic heart failure? A retrospective analysis of 5010 patients enrolled in Val-HeFT

被引：0
|
作者：
Krum, H
Carretta, E
Latini, R
Maggioni, A
Masson, S
机构：
[1] Mario Negri, Milan, Italy
[2] Monash Univ, Melbourne, Vic 3004, Australia
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3150
引用
收藏
页码：680 / 680
页数：1
相关论文
共 50 条
  • [31] Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT
    Krum, H
    Carson, P
    Farsang, C
    Maggioni, AP
    Glazer, RD
    Aknay, N
    Chiang, YT
    Cohn, JN
    EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (07) : 937 - 945
  • [32] Valsartan and C-reactive protein in chronic heart failure: data from the Val-HeFT trial
    Latini, R
    Anand, IS
    Masson, S
    Morris, E
    Signorini, S
    Carretta, E
    Besana, S
    Cohn, JN
    CIRCULATION, 2004, 110 (17) : 92 - 93
  • [33] Effect of valsartan on morbidity and mortality in patients with chronic heart failure receiving ACE inhibitors but not beta-blockers: Results from Val-HeFT
    Krum, H
    Farsang, C
    Maggioni, A
    CIRCULATION, 2002, 106 (19) : 511 - 511
  • [34] Effects of valsartan on left ventricular ejection fraction and diastolic diameter in patients with heart failure: Val-HeFT echocardiographic study
    Wong, M
    Staszewsky, L
    Latini, R
    Chiang, YT
    Volpi, A
    Hoglund, C
    Cohn, JN
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 141A - 141A
  • [35] Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure - The Valsartan Heart Failure Trial (Val-HeFT)
    Latini, R
    Masson, S
    Arland, I
    Judd, D
    Maggioni, AP
    Chiang, YT
    Bevilacqua, M
    Salio, M
    Cardano, P
    Dunselman, PHJM
    Holwerda, NJ
    Tognoni, G
    Cohn, JN
    CIRCULATION, 2002, 106 (19) : 2454 - 2458
  • [36] Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT
    Anand, Inder S.
    Rector, Thomas S.
    Kuskowski, Michael
    Adourian, Aram
    Muntendam, Pieter
    Cohn, Jay N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (05) : 511 - 518
  • [37] Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)
    Baruch, L
    Glazer, RD
    Aknay, N
    Vanhaecke, J
    Heywood, JT
    Anand, I
    Phil, D
    Krum, H
    Hester, A
    Cohn, JN
    AMERICAN HEART JOURNAL, 2004, 148 (06) : 951 - 957
  • [38] Statins in Patients With Established Heart Failure: Time for Reflection
    Pitt, Bertram
    Rosenson, Robert S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2023, 82 (05) : 345 - 346
  • [39] Heart Failure with Recovered Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival. Results from Val-HeFT
    Florea, Viorel G.
    Rector, Thomas S.
    Anand, Inder S.
    Cohn, Jay N.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (08) : S47 - S47
  • [40] COST/UTILITY ANALYSIS (CUA) OF VALSARTAN FOR THE TREATMENT OF CONGESTIVE HEART FAILURE (CHF) IN ITALY BASED ON THE VAL-HEFT TRIAL
    Pradelli, L.
    Iannazzo, S.
    Zaniolo, O.
    VALUE IN HEALTH, 2008, 11 (06) : A403 - A404
12345